tofacitinib and Arthritis--Reactive

tofacitinib has been researched along with Arthritis--Reactive* in 1 studies

Other Studies

1 other study(ies) available for tofacitinib and Arthritis--Reactive

ArticleYear
Successful use of tofacitinib in reactive arthritis refractory to conventional therapies - a case series.
    Modern rheumatology case reports, 2022, 06-24, Volume: 6, Issue:2

    Reactive arthritis is an immune-mediated aseptic arthritis resulting from either genitourinary or gastrointestinal tract in a genetically susceptible host. It commonly presents as oligoarthritis of the lower limbs with or without extra-articular features such as urethritis and non-purulent conjunctivitis. Therapies include non steroidal anti inflammatory drugs (NSAIDs), conventional disease modifying anti-rheumatic drugs (DMARDs) and, rarely, biologics in severe cases. We report the successful use of tofacitinib in four cases of reactive arthritis who failed to respond to conventional therapies.

    Topics: Antirheumatic Agents; Arthritis, Reactive; Humans; Piperidines; Pyrimidines

2022